Safety in these pediatric populations was consistent with the known safety profile across approved adult and pediatric indications1,2
Medidata Detect and Rave CTMS Have Improved Study Execution Through Role-Based Monitoring Workflows and Clinical Data Visualization for Hundreds of Customers Across More Than 9,000 Studies
First and only PARP inhibitor to improve invasive disease-free survival in patients
73% have cited fears like losing eyesight, painful procedure or long recovery period when it comes to cataract surgeries
The FDA informed Astellas that it did not have sufficient information to assess the risks to subjects
Most recently, she served as chief human resources officer at Vyripharm Enterprises.
This is the first Agilent lab to receive the My Green Lab Certification and plans are under way to certify additional labs.
With $120m jointly invested in the newly-formed initiative, and with other strategic investors expected to join, the venture will develop an alternative, plant-based ingredient using biotechnology
Revenues from operations for the full year ended March 31, 2022 stood at Rs. 590.05 crore as compared to Rs. 449.82 crore in FY21
TMA will leverage Syntegra's synthetic data engine to accelerate the building of predictive diagnostic algorithms
Subscribe To Our Newsletter & Stay Updated
